Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
Open Access
- 23 September 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 24 (4) , 571-581
Abstract
Accurate CNS tumor diagnosis can be challenging, and methylation profiling can serve as an adjunct to classify diagnostically difficult cases. An integrated diagnostic approach was employed for a consecutive series of 1258 surgical neuropathology samples obtained primarily in a consultation practice over 2-year period. DNA methylation profiling and classification using the DKFZ/Heidelberg CNS tumor classifier was performed, as well as unsupervised analyses of methylation data. Ancillary testing, where relevant, was performed. Among the received cases in consultation, a high-confidence methylation classifier score (>0.84) was reached in 66.4% of cases. The classifier impacted the diagnosis in 46.7% of these high-confidence classifier score cases, including a substantially new diagnosis in 26.9% cases. Among the 289 cases received with only a descriptive diagnosis, methylation was able to resolve approximately half (144, 49.8%) with high-confidence scores. Additional methods were able to resolve diagnostic uncertainty in 41.6% of the low-score cases. Tumor purity was significantly associated with classifier score (P = 1.15e−11). Deconvolution demonstrated that suspected glioblastomas (GBMs) matching as control/inflammatory brain tissue could be resolved into GBM methylation profiles, which provided a proof-of-concept approach to resolve tumor classification in the setting of low tumor purity. This work assesses the impact of a methylation classifier and additional methods in a consultative practice by defining the proportions with concordant vs change in diagnosis in a set of diagnostically challenging CNS tumors. We address approaches to low-confidence scores and confounding issues of low tumor purity.Keywords
Funding Information
- National Institutes of Health
- National Cancer Institute
- Center for Cancer Research
This publication has 26 references indexed in Scilit:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Systematic pan-cancer analysis of tumour purityNature Communications, 2015
- Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural SubtypeJournal of Neuropathology & Experimental Neurology, 2012
- Alterations in the RB1 Pathway in Low‐grade Diffuse Gliomas Lacking Common Genetic AlterationsBrain Pathology, 2011
- A DNA methylation fingerprint of 1628 human samplesGenome Research, 2011
- Extensive epigenetic reprogramming in human somatic tissues between fetus and adultEpigenetics & Chromatin, 2011
- Tissue-specific demethylation in CpG-poor promoters during cellular differentiationHuman Molecular Genetics, 2011
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patternsHuman Molecular Genetics, 2009
- Hypomethylation distinguishes genes of some human cancers from their normal counterpartsNature, 1983